Cargando…
Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)
Immunotherapy has emerged as a crucial treatment option, particularly for types of cancer that display resistance to conventional therapies. A remarkable breakthrough in this field is the development of chimeric antigen receptor (CAR) T cell therapy. CAR T cells are generated by engineering the T ce...
Autores principales: | Poojary, Rayansh, Song, Andy Fang, Song, Benny Shone, Song, Carly Shaw, Wang, Liqing, Song, Jianxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619195/ https://www.ncbi.nlm.nih.gov/pubmed/37920415 http://dx.doi.org/10.3892/mco.2023.2691 |
Ejemplares similares
-
Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
por: Shin, Seungyong, et al.
Publicado: (2023) -
Development of Auto Antigen-specific Regulatory T Cells for Diabetes Immunotherapy
por: Song, Jianxun
Publicado: (2016) -
Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
por: Brown, Kevin, et al.
Publicado: (2021) -
Research advances in chimeric antigen receptor-modified T-cell therapy (Review)
por: Luo, Yuxi, et al.
Publicado: (2021) -
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
por: Cartellieri, Marc, et al.
Publicado: (2010)